Intrafamilial clinical phenotypic heterogeneity with progranulin gene p.Glu498fs mutation

J Neurol Sci. 2012 May 15;316(1-2):189-90. doi: 10.1016/j.jns.2012.01.005. Epub 2012 Jan 26.

Abstract

A patient with a progressive aphasia syndrome underwent progranulin gene (GRN) testing in light of a family history of early-onset dementia in two of her brothers, one of whom had been previously examined and had the phenotype of frontal variant frontotemporal dementia. The proband was found to have the p.Glu498fs mutation. This is only the second English family, and the fifth family overall, to be described with this GRN mutation. There was marked intrafamilial phenotypic heterogeneity with respect to age at onset and clinical presentation. The mechanisms underpinning this heterogeneity, as seen with other GRN mutations, are currently unknown. Since all GRN mutations lead to progranulin haploinsufficiency, other modifying factors, possibly genetic, are implicated.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Female
  • Frontotemporal Dementia / diagnosis*
  • Frontotemporal Dementia / genetics*
  • Glutamic Acid / genetics
  • Haploinsufficiency / genetics
  • Humans
  • Intercellular Signaling Peptides and Proteins / deficiency
  • Intercellular Signaling Peptides and Proteins / genetics*
  • Male
  • Middle Aged
  • Mutation / genetics*
  • Phenotype*
  • Progranulins

Substances

  • GRN protein, human
  • Intercellular Signaling Peptides and Proteins
  • Progranulins
  • Glutamic Acid